Complement 1 is a health technology company dedicated to transforming cancer care through lifestyle medicine.
Complement 1 has raised $16.0M in total funding. The most recent round was Seed. The last funding was announced in April 2025.
Complement 1's investors include Blume Ventures, Owl Ventures.
Complement 1 is headquartered in Dover, United States.
Complement 1 is a health technology company dedicated to transforming cancer care through lifestyle medicine.
Complement 1 is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Complement 1 — Funding & Investors." VCBacked, April 25, 2025, https://www.vcbacked.co/company/complement-1. Accessed August 2, 2026.
VCBacked. (2025). Complement 1 — Funding & Investors. Retrieved August 2, 2026, from https://www.vcbacked.co/company/complement-1
{{cite web |title=Complement 1 — Funding & Investors |url=https://www.vcbacked.co/company/complement-1 |website=VCBacked |access-date=August 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated